{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:15:50Z","timestamp":1794060950478,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC3403400"],"award-info":[{"award-number":["2023YFC3403400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270125"],"award-info":[{"award-number":["82270125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Municipal Science and Technology Commission","doi-asserted-by":"crossref","award":["23HC1400400"],"award-info":[{"award-number":["23HC1400400"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03681-8","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T07:48:37Z","timestamp":1756799317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Spleen-targeted NeoPol-mL242 mRNA vaccine induces robust T-cell responses in a hepatocellular carcinoma model"],"prefix":"10.1186","volume":"23","author":[{"given":"Yufei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongrui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9155-9883","authenticated-orcid":false,"given":"Yuxuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"issue":"1","key":"3681_CR1","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"3681_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589\u2013604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"3681_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev-bioeng-110220-031722","volume":"24","author":"J Chen","year":"2022","unstructured":"Chen J, Chen J, Xu Q. Current developments and challenges of mRNA vaccines. Annu Rev Biomed Eng. 2022;24(1):85\u2013109.","journal-title":"Annu Rev Biomed Eng"},{"key":"3681_CR4","doi-asserted-by":"crossref","unstructured":"Hester CA, Yopp AC. Surgical Therapies in Hepatocellular Carcinoma, Hepatocellular Carcinoma2019, pp. 145\u2013167.","DOI":"10.1007\/978-3-030-21540-8_8"},{"issue":"10","key":"3681_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrd2130","volume":"5","author":"S Wilhelm","year":"2006","unstructured":"Wilhelm S, Carter C, Lynch M, Lowinger T, Dumas J, Smith RA, Schwartz B, Simantov R, Kelley S. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nat Rev Drug Discov. 2006;5(10):835\u201344.","journal-title":"Nat Rev Drug Discov"},{"key":"3681_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225525","author":"S Wang","year":"2022","unstructured":"Wang S, Wang Y, Yu J, Wu H, Zhou Y. Lenvatinib as first-line treatment for unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14225525.","journal-title":"Cancers (Basel)"},{"key":"3681_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17670-y","author":"C Robert","year":"2020","unstructured":"Robert C. A decade of immune-checkpoint inhibitors in cancer therapy. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/s41467-020-17670-y.","journal-title":"Nat Commun"},{"key":"3681_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134301","author":"NA Alturki","year":"2023","unstructured":"Alturki NA. Review of the immune checkpoint inhibitors in the context of cancer treatment. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12134301.","journal-title":"J Clin Med"},{"key":"3681_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06389-5","author":"L Meng","year":"2024","unstructured":"Meng L, Wu H, Wu J, Ding Pa, He J, Sang M, Liu L. Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAs involved in cancer hallmarks. Cell Death Dis. 2024. https:\/\/doi.org\/10.1038\/s41419-023-06389-5.","journal-title":"Cell Death Dis"},{"key":"3681_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1489827","author":"SH Khan","year":"2025","unstructured":"Khan SH, Choi Y, Veena M, Lee JK, Shin DS. Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2024.1489827.","journal-title":"Front Immunol"},{"key":"3681_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00459-7","author":"RC Sterner","year":"2021","unstructured":"Sterner RC, Sterner RM. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 2021. https:\/\/doi.org\/10.1038\/s41408-021-00459-7.","journal-title":"Blood Cancer J"},{"issue":"4","key":"3681_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41573-024-00896-6","volume":"23","author":"C Klein","year":"2024","unstructured":"Klein C, Brinkmann U, Reichert JM, Kontermann RE. The present and future of bispecific antibodies for cancer therapy. Nat Rev Drug Discov. 2024;23(4):301\u201319.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"3681_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41573-019-0028-1","volume":"18","author":"AF Labrijn","year":"2019","unstructured":"Labrijn AF, Janmaat ML, Reichert JM, Parren PWHI. Bispecific antibodies: a mechanistic review of the pipeline. Nat Rev Drug Discov. 2019;18(8):585\u2013608.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"3681_CR14","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nm.4356","volume":"23","author":"CR Stadler","year":"2017","unstructured":"Stadler CR, B\u00e4hr-Mahmud H, Celik L, Hebich B, Roth AS, Roth RP, Karik\u00f3 K, T\u00fcreci \u00d6, Sahin U. Elimination of large tumors in mice by mRNA-encoded bispecific antibodies. Nat Med. 2017;23(7):815\u20137.","journal-title":"Nat Med"},{"issue":"4","key":"3681_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","volume":"20","author":"C Yang","year":"2022","unstructured":"Yang C, Zhang H, Zhang L, Zhu AX, Bernards R, Qin W, Wang C. Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nat Reviews Gastroenterol Hepatol. 2022;20(4):203\u201322.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"3","key":"3681_CR16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41591-020-01206-4","volume":"27","author":"Z Hu","year":"2021","unstructured":"Hu Z, Leet DE, Alles\u00f8e RL, Oliveira G, Li S, Luoma AM, Liu J, Forman J, Huang T, Iorgulescu JB, Holden R, Sarkizova S, Gohil SH, Redd RA, Sun J, Elagina L, Giobbie-Hurder A, Zhang W, Peter L, Ciantra Z, Rodig S, Olive O, Shetty K, Pyrdol J, Uduman M, Lee PC, Bachireddy P, Buchbinder EI, Yoon CH, Neuberg D, Pentelute BL, Hacohen N, Livak KJ, Shukla SA, Olsen LR, Barouch DH, Wucherpfennig KW, Fritsch EF, Keskin DB, Wu CJ, Ott PA. Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma. Nat Med. 2021;27(3):515\u201325.","journal-title":"Nat Med"},{"key":"3681_CR17","doi-asserted-by":"crossref","unstructured":"Ott PA, Hu Z, Keskin DB, Shukla SA, Sun J, Bozym DJ, Zhang W, Luoma A, Giobbie-Hurder A, Peter L, Chen C, Olive O, Carter TA, Li S, Lieb DJ, Eisenhaure T, Gjini E, Stevens J, Lane WJ, Javeri I, Nellaiappan K, Salazar AM, Daley H, Seaman M, Buchbinder EI, Yoon CH, Harden M, Lennon N, Gabriel S, Rodig SJ, Barouch DH, Aster JC, Getz G, Wucherpfennig K, Neuberg D, Ritz J, Lander ES, Fritsch EF, Hacohen N, C.J., Wu. An immunogenic personal neoantigen vaccine for patients with melanoma, Nature 547(7662) (2017) 217\u2013221.","DOI":"10.1038\/nature22991"},{"key":"3681_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0103-y","author":"RE Hollingsworth","year":"2019","unstructured":"Hollingsworth RE, Jansen K. Turning the corner on therapeutic cancer vaccines. NPJ Vaccines. 2019. https:\/\/doi.org\/10.1038\/s41541-019-0103-y.","journal-title":"NPJ Vaccines"},{"key":"3681_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01844-5","author":"J Li","year":"2023","unstructured":"Li J, Xiao Z, Wang D, Jia L, Nie S, Zeng X, Hu W. The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells. Mol Cancer. 2023. https:\/\/doi.org\/10.1186\/s12943-023-01844-5.","journal-title":"Mol Cancer"},{"key":"3681_CR20","unstructured":"Vincent CMLaK. Noncoding regions are the main source of targetable tumor-specific antigens. Sci Transl Med (2018)."},{"issue":"13","key":"3681_CR21","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.7150\/thno.38742","volume":"10","author":"X Chen","year":"2020","unstructured":"Chen X, Yang J, Wang L, Liu B. Personalized neoantigen vaccination with synthetic long peptides: recent advances and future perspectives. Theranostics. 2020;10(13):6011\u201323.","journal-title":"Theranostics"},{"issue":"5","key":"3681_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nrc2373","volume":"8","author":"CJM Melief","year":"2008","unstructured":"Melief CJM, van der Burg SH. Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines. Nat Rev Cancer. 2008;8(5):351\u201360.","journal-title":"Nat Rev Cancer"},{"key":"3681_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01311-z","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang Z, Luo J, Han X, Wei Y, Wei X. mRNA vaccine: a potential therapeutic strategy. Mol Cancer. 2021. https:\/\/doi.org\/10.1186\/s12943-021-01311-z.","journal-title":"Mol Cancer"},{"key":"3681_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114961","author":"DD Kang","year":"2023","unstructured":"Kang DD, Li H, Dong Y. Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics. Adv Drug Deliv Rev. 2023. https:\/\/doi.org\/10.1016\/j.addr.2023.114961.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"3681_CR25","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary N, Weissman D, Whitehead KA. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discovery. 2021;20(11):817\u201338.","journal-title":"Nat Rev Drug Discovery"},{"key":"3681_CR26","doi-asserted-by":"crossref","unstructured":"Ma Y, VanKeulen-Miller R, Fenton OS. mRNA lipid nanoparticle formulation, characterization and evaluation. Nat Protoc (2025).","DOI":"10.1038\/s41596-024-01134-4"},{"issue":"8","key":"3681_CR27","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","volume":"23","author":"C Liu","year":"2023","unstructured":"Liu C, Shi Q, Huang X, Koo S, Kong N, Tao W. mRNA-based cancer therapeutics. Nat Rev Cancer. 2023;23(8):526\u201343.","journal-title":"Nat Rev Cancer"},{"key":"3681_CR28","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1021\/ja901655p","volume":"131","author":"AR Kore","year":"2009","unstructured":"Kore AR. Locked nucleic acid (LNA)-modified dinucleotide mRNA cap analogue: synthesis, enzymatic incorporation, and utilization. J Am Chem Soc. 2009;131:6364\u20135.","journal-title":"J Am Chem Soc"},{"key":"3681_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1512","author":"C Julius","year":"2018","unstructured":"Julius C, Yuzenkova Y. Noncanonical RNA-capping: discovery, mechanism, and physiological role debate. WIREs RNA. 2018. https:\/\/doi.org\/10.1002\/wrna.1512.","journal-title":"WIREs RNA"},{"issue":"16","key":"3681_CR30","doi-asserted-by":"publisher","first-page":"10245","DOI":"10.1093\/nar\/gku757","volume":"42","author":"J Kowalska","year":"2014","unstructured":"Kowalska J, Wypijewska del Nogal A, Darzynkiewicz ZM, Buck J, Nicola C, Kuhn AN, Lukaszewicz M, Zuberek J, Strenkowska M, Ziemniak M, Maciejczyk M, Bojarska E, Rhoads RE, Darzynkiewicz E, Sahin U, Jemielity J. Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes. Nucleic Acids Res. 2014;42(16):10245\u201364.","journal-title":"Nucleic Acids Res"},{"key":"3681_CR31","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a034728","author":"C Mayr","year":"2019","unstructured":"Mayr C. What are 3\u2032 UTRs doing? Cold Spring Harb Perspect Biol. 2019. https:\/\/doi.org\/10.1101\/cshperspect.a034728","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"20","key":"3681_CR32","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1021\/acs.accounts.3c00442","volume":"56","author":"M Warminski","year":"2023","unstructured":"Warminski M, Mamot A, Depaix A, Kowalska J, Jemielity J. Chemical modifications of mRNA ends for therapeutic applications. Acc Chem Res. 2023;56(20):2814\u201326.","journal-title":"Acc Chem Res"},{"key":"3681_CR33","doi-asserted-by":"publisher","first-page":"7059","DOI":"10.1093\/nar\/14.17.7059","volume":"14","author":"E Whitelaw","year":"1986","unstructured":"Whitelaw E. Globin gene transcripts can utilize histone gene 3\u2019 end processing signals. Nucleic Acids Res. 1986;14:7059\u201370.","journal-title":"Nucleic Acids Res"},{"key":"3681_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0092-8674(76)90184-7","volume":"8","author":"MT D.a.N","year":"1976","unstructured":"D.a.N MT. The translational capacity of deadenylated ovalbumin messenger RNA. Cell. 1976;8:51\u20138.","journal-title":"Cell"},{"issue":"13","key":"3681_CR35","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1182\/blood-2006-04-015024","volume":"108","author":"S Holtkamp","year":"2006","unstructured":"Holtkamp S, Kreiter S, Selmi A, Simon P, Koslowski M, Huber C, T\u00fcreci Oz, Sahin U. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood. 2006;108(13):4009\u201317.","journal-title":"Blood"},{"key":"3681_CR36","doi-asserted-by":"crossref","unstructured":"Travieso T, Li J, Mahesh S, J.D.F.R.E. Mello M, Blasi. The use of viral vectors in vaccine development. Npj Vaccines 7(1) (2022).","DOI":"10.1038\/s41541-022-00503-y"},{"key":"3681_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01408-5","author":"S Wang","year":"2023","unstructured":"Wang S, Liang B, Wang W, Li L, Feng N, Zhao Y, Wang T, Yan F, Yang S, Xia X. Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases. Signal Transduct Target Ther. 2023. https:\/\/doi.org\/10.1038\/s41392-023-01408-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"3681_CR38","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.matt.2022.03.006","volume":"5","author":"P Huang","year":"2022","unstructured":"Huang P, Deng H, Zhou Y, Chen X. The roles of polymers in mRNA delivery. Matter. 2022;5(6):1670\u201399.","journal-title":"Matter"},{"key":"3681_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201805308","author":"Q Cheng","year":"2018","unstructured":"Cheng Q, Wei T, Jia Y, Farbiak L, Zhou K, Zhang S, Wei Y, Zhu H, Siegwart DJ. Dendrimer-based lipid nanoparticles deliver therapeutic FAH mRNA to normalize liver function and extend survival in a mouse model of hepatorenal tyrosinemia type I. Adv Mater. 2018. https:\/\/doi.org\/10.1002\/adma.201805308.","journal-title":"Adv Mater"},{"key":"3681_CR40","doi-asserted-by":"crossref","unstructured":"Ye JCaZ. Lipid nanoparticle-mediated lymph node\u2013targeting delivery of mRNA cancer vaccine elicits robust CD8\u2009+\u2009T cell response, Proceedings of the National Academy of Sciences 119 (2022).","DOI":"10.1073\/pnas.2207841119"},{"issue":"1","key":"3681_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11095-022-03460-2","volume":"40","author":"D Sun","year":"2023","unstructured":"Sun D, Lu Z-R. Structure and function of cationic and ionizable lipids for nucleic acid delivery. Pharm Res. 2023;40(1):27\u201346.","journal-title":"Pharm Res"},{"issue":"2","key":"3681_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1586\/14760584.2014.957684","volume":"14","author":"D Benteyn","year":"2014","unstructured":"Benteyn D, Heirman C, Bonehill A, Thielemans K, Breckpot K. mRNA-based dendritic cell vaccines. Expert Rev Vaccines. 2014;14(2):161\u201376.","journal-title":"Expert Rev Vaccines"},{"key":"3681_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56004-8","author":"J Ma","year":"2025","unstructured":"Ma J, Ayres CM, Brambley CA, Chandran SS, Rosales TJ, Perera WWJG, Eldaly B, Murray WT, Corcelli SA, Kovrigin EL, Klebanoff CA, Baker BM. Dynamic allostery in the peptide\/MHC complex enables TCR neoantigen selectivity. Nat Commun. 2025. https:\/\/doi.org\/10.1038\/s41467-025-56004-8.","journal-title":"Nat Commun"},{"issue":"8","key":"3681_CR44","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1021\/acs.bioconjchem.1c00285","volume":"32","author":"H Moulahoum","year":"2021","unstructured":"Moulahoum H, Ghorbanizamani F, Zihnioglu F, Timur S. Surface biomodification of liposomes and polymersomes for efficient targeted drug delivery. Bioconjug Chem. 2021;32(8):1491\u2013502.","journal-title":"Bioconjug Chem"},{"key":"3681_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113687","author":"Y Suzuki","year":"2025","unstructured":"Suzuki Y, Yakuwa M, Sato M, Samaridou E, Beck-Broichsitter M, Maeki M, Tokeshi M, Yamada Y, Harashima H, Sato Y. Splenic B cell-targeting lipid nanoparticles for safe and effective mRNA vaccine delivery. J Controlled Release. 2025. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113687.","journal-title":"J Controlled Release"},{"issue":"4","key":"3681_CR46","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng Q, Wei T, Farbiak L, Johnson LT, Dilliard SA, Siegwart DJ. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat Nanotechnol. 2020;15(4):313\u201320.","journal-title":"Nat Nanotechnol"},{"key":"3681_CR47","doi-asserted-by":"crossref","unstructured":"Xu S, Liang D, Wang Q, Cheng Y, Xie D, Gui Y, Zhang H, Feng C, Zhao F, Ren W, Sun G, Yang Y, Li L, Lai Y, Fu B, Lu Y, Wang ZJ, Wu Y. In vivo genome editing of human hematopoietic stem cells for treatment of blood disorders by mRNA delivery, (2024).","DOI":"10.1101\/2024.10.28.620445"},{"issue":"1","key":"3681_CR48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ymthe.2024.10.003","volume":"33","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Chen S, Hsiao S, Zhang H, Xie D, Wang ZJ, Ren W, Liu M, Liao J, Wu Y. Efficient and safe in vivo treatment of primary hyperoxaluria type 1 via LNP-CRISPR-Cas9-mediated glycolate oxidase disruption. Mol Ther. 2025;33(1):104\u201318.","journal-title":"Mol Ther"},{"issue":"7549","key":"3681_CR49","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nature14426","volume":"520","author":"S Kreiter","year":"2015","unstructured":"Kreiter S, Vormehr M, van de Roemer N, Diken M, L\u00f6wer M, Diekmann J, Boegel S, Schr\u00f6rs B, Vascotto F, Castle JC, Tadmor AD, Schoenberger SP, Huber C, T\u00fcreci \u00d6, Sahin U. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 2015;520(7549):692\u20136.","journal-title":"Nature"},{"key":"3681_CR50","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004389","author":"H Chen","year":"2022","unstructured":"Chen H, Li Z, Qiu L, Dong X, Chen G, Shi Y, Cai L, Liu W, Ye H, Zhou Y, Ouyang J, Cai Z, Liu X. Personalized neoantigen vaccine combined with PD-1 blockade increases CD8\u2009+\u2009tissue-resident memory T-cell infiltration in preclinical hepatocellular carcinoma models. J Immunother Cancer. 2022. https:\/\/doi.org\/10.1136\/jitc-2021-004389.","journal-title":"J Immunother Cancer"},{"issue":"7662","key":"3681_CR51","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature23003","volume":"547","author":"U Sahin","year":"2017","unstructured":"Sahin U, Derhovanessian E, Miller M, Kloke B-P, Simon P, L\u00f6wer M, Bukur V, Tadmor AD, Luxemburger U, Schr\u00f6rs B, Omokoko T, Vormehr M, Albrecht C, Paruzynski A, Kuhn AN, Buck J, Heesch S, Schreeb KH, M\u00fcller F, Ortseifer I, Vogler I, Godehardt E, Attig S, Rae R, Breitkreuz A, Tolliver C, Suchan M, Martic G, Hohberger A, Sorn P, Diekmann J, Ciesla J, Waksmann O, Br\u00fcck A-K, Witt M, Zillgen M, Rothermel A, Kasemann B, Langer D, Bolte S, Diken M, Kreiter S, Nemecek R, Gebhardt C, Grabbe S, H\u00f6ller C, Utikal J, Huber C, Loquai C, T\u00fcreci \u00d6. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature. 2017;547(7662):222\u20136.","journal-title":"Nature"},{"issue":"7963","key":"3681_CR52","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","volume":"618","author":"LA Rojas","year":"2023","unstructured":"Rojas LA, Sethna Z, Soares KC, Olcese C, Pang N, Patterson E, Lihm J, Ceglia N, Guasp P, Chu A, Yu R, Chandra AK, Waters T, Ruan J, Amisaki M, Zebboudj A, Odgerel Z, Payne G, Derhovanessian E, M\u00fcller F, Rhee I, Yadav M, Dobrin A, Sadelain M, \u0141uksza M, Cohen N, Tang L, Basturk O, G\u00f6nen M, Katz S, Do RK, Epstein AS, Momtaz P, Park W, Sugarman R, Varghese AM, Won E, Desai A, Wei AC, D\u2019Angelica MI, Kingham TP, Mellman I, Merghoub T, Wolchok JD, Sahin U, T\u00fcreci \u00d6, Greenbaum BD, Jarnagin WR, Drebin J, O\u2019Reilly EM, Balachandran VP. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature. 2023;618(7963):144\u201350.","journal-title":"Nature"},{"key":"3681_CR53","doi-asserted-by":"crossref","unstructured":"Sethna Z, Guasp P, Reiche C, Milighetti M, Ceglia N, Patterson E, Lihm J, Payne G, Lyudovyk O, Rojas LA, Pang N, Ohmoto A, Amisaki M, Zebboudj A, Odgerel Z, Bruno EM, Zhang SL, Cheng C, Elhanati Y, Derhovanessian E, Manning L, M\u00fcller F, Rhee I, Yadav M, Merghoub T, Wolchok JD, Basturk O, G\u00f6nen M, Epstein AS, Momtaz P, Park W, Sugarman R, Varghese AM, Won E, Desai A, Wei AC, D\u2019Angelica MI, Kingham TP, Soares KC, Jarnagin WR, Drebin J, O\u2019Reilly EM, Mellman I, Sahin U, T\u00fcreci \u00d6, Greenbaum BD, Balachandran VP. RNA neoantigen vaccines prime long-lived CD8\u2009+\u2009T cells in pancreatic cancer. Nature (2025).","DOI":"10.1038\/s41586-024-08508-4"},{"issue":"5","key":"3681_CR54","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41591-019-0401-y","volume":"25","author":"Y Wu","year":"2019","unstructured":"Wu Y, Zeng J, Roscoe BP, Liu P, Yao Q, Lazzarotto CR, Clement K, Cole MA, Luk K, Baricordi C, Shen AH, Ren C, Esrick EB, Manis JP, Dorfman DM, Williams DA, Biffi A, Brugnara C, Biasco L, Brendel C, Pinello L, Tsai SQ, Wolfe SA, Bauer DE. Highly efficient therapeutic gene editing of human hematopoietic stem cells. Nat Med. 2019;25(5):776\u201383.","journal-title":"Nat Med"},{"key":"3681_CR55","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/12.5.333","volume":"12","author":"P Pizzolato","year":"1964","unstructured":"Pizzolato P. Histochemical recognition of calcium. J Histochem Cytochem. 1964;12:333\u20136.","journal-title":"J Histochem Cytochem"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03681-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03681-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03681-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:13:02Z","timestamp":1757477582000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03681-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3681"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03681-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"14 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"602"}}